rs1952060
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_013266.4(CTNNA3):c.1047+137141A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.453 in 148,590 control chromosomes in the GnomAD database, including 15,714 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.45 ( 15714 hom., cov: 24)
Consequence
CTNNA3
NM_013266.4 intron
NM_013266.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0770
Publications
3 publications found
Genes affected
CTNNA3 (HGNC:2511): (catenin alpha 3) This gene encodes a protein that belongs to the vinculin/alpha-catenin family. The encoded protein plays a role in cell-cell adhesion in muscle cells. Mutations in this gene are associated with arrhythmogenic right ventricular dysplasia, familial 13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
LRRTM3 (HGNC:19410): (leucine rich repeat transmembrane neuronal 3) Involved in presynapse assembly. Acts upstream of or within positive regulation of amyloid-beta formation. Is active in glutamatergic synapse. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.459 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CTNNA3 | ENST00000433211.7 | c.1047+137141A>G | intron_variant | Intron 7 of 17 | 1 | NM_013266.4 | ENSP00000389714.1 | |||
| LRRTM3 | ENST00000361320.5 | c.1537-54411T>C | intron_variant | Intron 2 of 2 | 1 | NM_178011.5 | ENSP00000355187.3 |
Frequencies
GnomAD3 genomes AF: 0.453 AC: 67253AN: 148512Hom.: 15708 Cov.: 24 show subpopulations
GnomAD3 genomes
AF:
AC:
67253
AN:
148512
Hom.:
Cov.:
24
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.453 AC: 67278AN: 148590Hom.: 15714 Cov.: 24 AF XY: 0.451 AC XY: 32582AN XY: 72260 show subpopulations
GnomAD4 genome
AF:
AC:
67278
AN:
148590
Hom.:
Cov.:
24
AF XY:
AC XY:
32582
AN XY:
72260
show subpopulations
African (AFR)
AF:
AC:
18279
AN:
40292
American (AMR)
AF:
AC:
6222
AN:
14946
Ashkenazi Jewish (ASJ)
AF:
AC:
2014
AN:
3446
East Asian (EAS)
AF:
AC:
1103
AN:
5072
South Asian (SAS)
AF:
AC:
2207
AN:
4702
European-Finnish (FIN)
AF:
AC:
4682
AN:
9594
Middle Eastern (MID)
AF:
AC:
177
AN:
286
European-Non Finnish (NFE)
AF:
AC:
31141
AN:
67284
Other (OTH)
AF:
AC:
995
AN:
2060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
1682
3364
5045
6727
8409
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
618
1236
1854
2472
3090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1302
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.